Abiopharma

News list

Otsuka Takashi 🟢 acquired 15.8K shares (1 derivative) of ORIX CORP (IX) at $38.22 Transaction Date: Jun 25, 2026 | Filing ID: 281791

Full text

News bot June 25, 2026, 10:30 a.m.
🔍 Otsuka Takashi (Executive)

Company: ORIX CORP (IX)

Report Date: 2026-06-25
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 15,763
Detailed Transactions and Holdings:
- Acquired 13 shares of Common Stock at $38.22 per share (Direct)
  Date: 2026-05-20 | Code: P | equity_swap_involved: false | shares_owned_after: 2,332.49 | transaction_form_type: 5
- Acquired 15,750 shares of Share-based Compensation Points (Derivative)
  Date: 2026-06-23 | Code: J | equity_swap_involved: false | shares_owned_after: 61,039.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each point represents a right to receive one share of Common Stock.
- F2: The reported derivative securities represent share-based compensation granted under ORIX Corporation's share-based compensation program, which entitles the Reporting Person to receive the stated amount of Common Stock upon retirement.
- REMARKS: Managing Executive Officer, Chief Risk Officer